An update from GoodRx Holdings ( (GDRX) ) is now available.
On January 21, 2025, GoodRx Holdings announced the appointment of Scott Wagner as a Class II director and Co-Chair of the Board, following his tenure as Interim CEO. Wagner’s extensive leadership experience, including his role at GoDaddy, is expected to enhance the company’s strategic direction. Simon Patterson resigned from the Board, with no disagreements cited, and his vacancy was filled by Wagner. Wagner will receive compensation in line with GoodRx’s Non-Employee Director Compensation Program.
More about GoodRx Holdings
GoodRx Holdings operates in the digital healthcare sector, focusing on providing consumers with access to affordable prescription medications through its platform.
YTD Price Performance: 3.29%
Average Trading Volume: 1,484,860
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.8B
See more insights into GDRX stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “Be the Leader You’ve Been Complaining For!” Paramount Stock (NASDAQ:PARA) Dips as Paramount Pulls Out of Politics
- Don’t “Get Rid of All Your Engine Designers”: Ford Stock (NYSE:F) Dips as it Brings Back a Big Name in Internal Combustion
- “Advanced Silicon Wafer Tests” Start; Intel Stock (NASDAQ:INTC) Slips